Save time and get answers to complex questions with AI chat
When will a generic version of xiaflex be available?The expiration date of the key patent for guselkumab?Guselkumab loss of exclusitivy?Brenzavvy discontinuation?How much is mebendazole?
See the DrugPatentWatch profile for Fycompa
Fycompa is the brand name for perampanel, an anti-seizure medicine used to treat certain forms of epilepsy.
Fycompa/perampanel is prescribed for partial-onset seizures (focal seizures) in people with epilepsy, typically as an add-on (adjunctive) therapy. It may also be used for primary generalized tonic-clonic seizures in some treatment settings, depending on local prescribing guidance.
Fycompa was developed and marketed by Eisai.
If you’re looking for details such as patent status or exclusivity information related to perampanel/Fycompa, DrugPatentWatch tracks these kinds of updates and documents: https://www.drugpatentwatch.com/
Other Questions About Fycompa :